SCHEMBL16793761

SCHEMBL16793761

Cc1n[nH]cc1Nc1nccc(-c2ccc(CNC(=O)N3CC(OC(C)C)C3)c(C(F)(F)F)c2)n1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BTK Q06187 11/20 0.72
▸ CD69 Q07108 2/20 0.59
▸ JAK2 O60674 1/20 0.59
▸ CYP3A4 P08684 1/20 0.59
▸ HRH2 P25021 1/20 0.59
▸ CDK7 P50613 1/20 0.59
▸ AAK1 Q2M2I8 1/20 0.59
▸ MAP3K19 Q56UN5 1/20 0.59
▸ CDKL2 Q92772 1/20 0.59
▸ RIOK1 Q9BRS2 1/20 0.59
▸ RIOK2 Q9BVS4 1/20 0.59
▸ BMP2K Q9NSY1 1/20 0.59
▸ ABL1 P00519 9/20 0.42
▸ BCR P11274 6/20 0.42
▸ LYN P07948 5/20 0.41
▸ PDGFRB P09619 2/20 0.41
▸ RIPK2 O43353 1/20 0.41
▸ LCK P06239 1/20 0.41
▸ FYN P06241 1/20 0.41
▸ RET P07949 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16794206 0.90 BTK (0.71) BTKCD69JAK2CYP3A4HRH2
SCHEMBL18170405 0.84 BTK (1.00) BTKCD69JAK2CYP3A4HRH2
SCHEMBL16794064 0.82 BTK (0.87) BTKCD69JAK2CYP3A4HRH2
SCHEMBL16794271 0.82 BTK (0.59) BTKCD69JAK2CYP3A4HRH2
SCHEMBL18170415 0.82 BTK (0.86) BTKCD69JAK2CYP3A4HRH2
SCHEMBL16794281 0.81 BTK (0.56) BTKCD69JAK2CYP3A4HRH2
SCHEMBL16794157 0.80 BTK (0.84) BTKCD69JAK2CYP3A4HRH2
SCHEMBL16793877 0.79 BTK (0.69) BTKCD69JAK2CYP3A4HRH2
SCHEMBL16794500 0.78 BTK (0.79) BTKCD69JAK2CYP3A4HRH2
SCHEMBL16794508 0.78 BTK (0.79) BTKCD69JAK2CYP3A4HRH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3080103-A1 BIARYL COMPOUNDS USEFUL FOR THE TREATMENT OF HUMAN DISEASES IN ONCOLOGY, NEUROLOGY AND IMMUNOLOGY Biogen MA Inc. (US) 2016-10-19 — — EP disclosed
WO-2015089337-A1 BIARYL COMPOUNDS USEFUL FOR THE TREATMENT OF HUMAN DISEASES IN ONCOLOGY, NEUROLOGY AND IMMUNOLOGY BIOGEN IDEC MA INC. (US) 2015-06-18 — — WO disclosed
Send feedback